# Sanofi-Aventis R&D – FDA Inspection, Mar 28, 2017

Source: https://www.keypedia.com/records/fda_inspections/sanofi-aventis-rd/45b4be84-f4b5-45d1-a6ad-83875e2869cc
Source feed: FDA_Inspections

> FDA inspection 1010703 of Sanofi-Aventis R&D, March 28, 2017. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010703
- Company Name: Sanofi-Aventis R&D
- Inspection Date: 2017-03-28
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 844908 - 2013-08-09
- FDA Inspection 594630 - 2009-06-05

## Related Officers

- [Company Rep](https://www.keypedia.com/people/neali-h-lucas/2f08b1c2-8a68-4785-a587-0112e54f6774)

Company: https://www.keypedia.com/companies/sanofi-aventis-rd/79a6a512-2c1f-4f76-9377-fcf53600e60b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c